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Abstract
Background: The use of health-related quality of life (HRQOL) measurements has been increased
progressively in health surveys. These measurements document the functional and psychosocial outcomes
of health conditions and complement clinical indicators to provide a comprehensive description of
individuals and populations' health. The Pediatric Quality of Life Inventory™ (PedsQL™) is a promising
instrument with age-appropriate versions. The objective of the current paper was to evaluate the
psychometric properties of the PedsQL™ 3.0 Cancer Module cross-culturally adapted for use in Brazil.
Methods: A cross-sectional study was developed with 190 Brazilian families of individuals from 2 to 18
years of age, of both genders, with cancer in various phases of treatment or control. Subjects were
recruited by means of convenience samples from the Pediatric Hematology/Oncology Centers at two
public hospitals. 'In-treatment' status was defined as individuals who were receiving medical care to induce
remission. 'Off-treatment' status was defined as individuals for whom all therapy was completed for a
period of at least one month. Reliability was determined through test-retest reliability and internal
consistency. The validity of the Cancer Module was determined through discriminant and convergent
validity. Correlations between the scores obtained by the children/adolescents with cancer and their
guardians were assessed.
Results: Test-retest reliability demonstrated good correlation (0.69–0.90 for children/adolescents; 0.71–
0.93 for guardians) and adequate agreement of the items (0.26–0.85 for children/adolescents; 0.25–0.87
for guardians). Internal consistency demonstrated adequate indices in comparisons between groups (α =
0.78–0.80 for children and adolescents; 0.68–0.88 for guardians). The 'pain and hurt', 'nausea', 'procedural
anxiety' and 'treatment anxiety' subscales proved capable of distinguishing the groups of children in
treatment and off treatment (p < 0.05). Positive significant correlations were observed between the scores
of the PedsQL™ 3.0 Cancer Module and the PedsQL™ 4.0 Generic Core scales. Weak correlations were
found between the reports of the children and those of the guardians.
Conclusion: The Brazilian version of the PedsQL™ 3.0 Cancer Module exhibited good measurement
properties regarding reproducibility and construct validity.
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Background
Childhood cancer represents from 0.5 to 3.0 percent of
malignant tumors in the world. In Brazil, the estimated
incidence of children with tumors in 2006 was 2.5 percent
of all cases of malignant neoplasms (11,800 individuals
in the 0 to 18-year-old age group). The significant progress
in anti-neoplasm therapy has led to a reduction in mortal-
ity rates in the last 40 years. Currently, 50 to 70 percent of
pediatric cancer patients can be cured if diagnosed and
treated early [1,2]. As a result of this increased survival
rate, there have been a growing number of studies assess-
ing health-related quality of life (HRQOL) in pediatric
patients with cancer both during and following treatment
[1,3,4].
Disease-specific HRQOL assessment instruments have
been developed to determine the impact of disease and
treatment on the quality of life of patients. Moreover,
decisions for the implementation of improvements in
public healthcare may be adopted based on the impact of
interventions on quality of life [1]. However, there are a
limited number of instruments designed to measure the
HRQOL of pediatric patients with cancer [5-7]. Research
carried out on the Medline database involving studies
from 1950 to 2006 and using the descriptors 'neoplasms',
'quality of life', 'questionnaire' and 'children' revealed 193
published articles. An analysis of these publications iden-
tified three disease-specific instruments for pediatric can-
cer (Pediatric Quality of Life Inventory™ (PedsQL™) 3.0
Cancer Module, Quality of Life in Childhood Cancer, and
the Minneapolis-Manchester Quality of Life Instrument),
none of which had yet been translated and validated for
Brazilian Portuguese.
The decision was made to use the PedsQL™ 3.0 Cancer
Module to assess the impact of cancer on the HRQOL of
children and adolescents. The PedsQL™ 3.0 Cancer Mod-
ule is disease-specific HRQOL instrument developed to
measure the impact of symptoms and treatment on the
quality of life of pediatric patients with cancer. This deci-
sion was based on the fact that it is a multidimensional,
cancer-specific instrument of easy comprehension and
designed for pediatric patients between the ages of 2 and
18 years. Furthermore, it is available in a self-report ver-
sion designed for children/adolescents and a proxy-report
version for guardians.
The aim of the present study was to test the psychometric
properties of the PedsQL™ 3.0 Cancer Module cross-cul-
turally adapted to Brazilian Portuguese.
Method
Target population
The present validation study was developed in the city of
Belo Horizonte, Minas Gerais, Brazil, from August
through November 2006. The city is located in the central
southern region of the state. It has an extension of 330.93
km2 and 100% of the population resides in urban areas
(2,238,526 inhabitants).
Subjects were recruited by means of convenience samples
from the Pediatric Hematology/Oncology Centers at two
public hospitals of the city. A total of 190 families of Bra-
zilian children between the ages of 2 and 18 years, of both
genders, with malignant neoplasm in various phases of
treatment or control of the disease participated in the
study. 'In-treatment' status was defined as individuals
who were receiving medical care to induce remission (n =
140, 73.7%). 'Off-treatment' status was defined as indi-
viduals for whom all therapy was completed for a period
of at least one month (n = 50, 26.3%) [1]. The existence
of another illness or concomitant syndrome to the malig-
nant neoplasm was established as an exclusion criterion.
The choice of age group was determined by the targeted
age range of the selected instrument.
The instruments were applied to pediatric patients
between the ages of 5 and 18 years (n = 124). Twelve chil-
dren did not answer the questionnaires. All guardians
(88.4% parents, 11.6% others) answered the instruments
(n = 190) reporting on the quality of life of children. Chil-
dren between the ages of 2 and 4 years (n = 54) did not
answer the questionnaires, as consistent with the instru-
ment requirements. All guardians (88.4% parents, 11.6%
others) answered the questionnaires (n = 190) reporting
on the quality of life of children. Patients and guardians
present at the hospitals on the days scheduled for the
interviews were selected to participate in the study. The
PedsQL™ 3.0 Cancer Module 3.0 and PedsQL™ 4.0
Generic Core Scales were administered at the hospital
internment units (n = 35, 18.4%) and the outpatient treat-
ment units (n = 155, 81.6%) while the families awaited
medical care.
The questionnaires were administered by means of inter-
views with the children/adolescents as well as the guardi-
ans, who were interviewed separately. During the
interviews, the guardians also responded to a form regard-
ing information on age, family relation and degree of
schooling. In order to characterize the families in eco-
nomic terms, the Brazilian Economic Classification Crite-
ria was used as the standard of segmentation of the
population into economic classes. It is composed of five
levels (A, B, C, D, E), for which A is the highest and E the
lowest. The goal of this classification system is to estimate
the buying power of each family, as measured by the
quantity of products each family can afford [8].
Interviews were performed individually by the researcher
in a room reserved specifically for this end. Prior to theHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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interviews, authorizations were obtained from the
Research Ethics Committees of the institutions involved.
Terms of informed consent were also obtained from the
participants.
Instruments
The Pediatric Quality of Life Inventory™ (PedsQL™) 3.0
Cancer Module is a multidimensional instrument devel-
oped by Varni et al. [9] to assess the impact of the disease
and treatment on the HRQOL of pediatric cancer patients.
The instrument was developed in versions for individuals
in the following age groups: 5–7, 8–12 and 13–18 years;
as well as for the guardians of individuals in the following
age groups: 2–4, 5–7, 8–12 and 13–18 years. There is no
self-report version for children between the ages of 2 and
4 years. It is structurally composed of 27 items distributed
among 8 subscales: pain and hurt (2 items), nausea (5
items), procedural anxiety (3 items), treatment anxiety (3
items), worry (3 items), cognitive problems (5 items),
perceived physical appearance (3 items) and communica-
tion (3 items). The scale has five Likert response options,
'never', 'almost never', 'sometimes', 'often' and 'almost
always' (corresponding to scores of 100, 75, 50, 25, 0). For
the versions adapted to children between the ages of 5 and
7 years, there are only three response options: 'never',
'sometimes' and 'almost always' (100, 50, 0). For this age,
a Face Scale was used, comprised of 3 pictures of facial
expressions varying from a smiling face to a very sad face
to indicate no problem/no difficulty/no pain to a lot of
problems/difficulty/worst pain. Regarding the interpreta-
tion of the scale, higher scores indicate lower levels of dif-
ficulties related to the disease and/or treatment.
The PedsQL™ 4.0 Generic Core Scales was used to com-
pare with the PedsQL™ 3.0 Cancer Module in order to
evaluate its construct validity. The Generic Scale is made
up of 23 items distributed among 4 subscales: physical
functioning (8 items), emotional functioning (5 items),
social functioning (5 items) and school functioning (5
items). It can be used in studies assessing the HRQOL
healthy children and adolescents and pediatric patients
with acute and chronic health conditions. It is available in
versions for children in the age groups 5–7, 8–12 and 13–
18 years; as well as the guardians of the children in the age
groups: 2–4, 5–7, 8–12 and 13–18 years. As with the Ped-
sQL™ 3.0 Cancer Module, the scale is made up of five Lik-
ert response options. Regarding interpretation, three
scores can be obtained: the total score; the score referring
to physical health (score of the physical functioning sub-
scale); and the score referring to psychosocial health
(combined scores of the emotional functioning, social
functioning and school functioning subscales). Higher
scores indicate a better quality of life.
Statistical analysis
Test-retest reliability was determined through the calcula-
tion of the Intraclass Correlation Coefficient (ICC) regard-
ing the scores of the 8 subscales of the PedsQL™ Cancer
Module. 95% confidence intervals were estimated. The
Intraclass Correlation Coefficient was measured according
to the following values: ≤0.40 weak correlation; 0.41–
0.60 moderate correlation; 0.61–0.80 good correlation;
and 0.81–1.00 excellent correlation [10,11]. A scale with
ordered categories implies that disagreement between dif-
ferent pairs of categories signifies different levels of seri-
ousness depending on their position in the sequence. The
Weighted Kappa Coefficient (kw) was also calculated for
each question of the instrument to measure the degree of
agreement of each pair of observations. The criteria
described by Landis & Koch [12] were considered in the
interpretation of agreement: -1.0 to 0.0 poor; 0.0 to 0.20
discrete; 0.20 to 0.40 regular; 0.40 to 0.60 moderate; 0.60
to 0.80 substantial; 0.80 to 1.00 nearly perfect. The Ped-
sQL™ Cancer Module instrument was administered twice
by the same researcher to 50 study participant families
(26.3% of the overall sample), with an interval of 7 days
between applications.
Values regarding the internal consistency of the PedsQL™
3.0 Cancer Module total scale score and subscales were
estimated by means of Cronbach's Alpha Coefficient. Val-
ues ≥ 0.70 were considered acceptable for comparisons
between groups [13-15]. Spearman's Correlation Coeffi-
cient was calculated to assess the correlation of each item
with its respective subscale. Corrected Item-Total Correla-
tion Coefficients were obtained, considering values ≥0.20
as acceptable [16].
Discriminant validity of the PedsQL™ 3.0 Cancer Module
was determined by means of a comparison between the
scores determined by the known groups approach
(patients in treatment and off treatment). Patients in treat-
ment were hypothesized to demonstrate lower scores on
the 8 subscales of the PedsQL™3.0 Cancer Module than
patients off treatment, signifying greater difficulties and
limitations due to the disease and treatment [15]. The
Mann-Whitney test was utilized for the analysis of this
hypothesis.
Construct validity was assessed by means of correlation
analysis between the subscale scores of the PedsQL™ 3.0
Cancer Module and the scores of the PedsQL™ 4.0 Generic
Core Scale Computing the inter-correlations among scales
provides initial information on the construct validity of
an instrument [14]. We hypothesized that greater cancer-
specific symptoms or problems would be correlated with
lower overall generic HRQOL based on the conceptualiza-
tion of disease-specific symptoms as causal indicators ofHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
Page 4 of 11
(page number not for citation purposes)
generic HRQOL [17]. Spearman's Correlation Coefficient
was utilized in these analyses.
The correlation between the scores obtained on the ver-
sions applied to the children/adolescents and those
applied to the guardians was determined through correla-
tion coefficients. The Intraclass Correlation Coefficients
(ICC) were computed. The SPSS for Windows (version
12.0) and Microsoft Excel software programs were used
for the data analysis.
Results
Characterization of the sample – descriptive analysis
The study involved a sample totaling 190 individuals and
their families in accordance with the inclusion criteria.
Distribution per age group proved to be uniform (2–4,
28.4%; 5–7, 22.1%; 8–12, 29.0%; 13–18, 20.5%) and
65.8% of the children/adolescents were male. The average
age of the guardians was 35.6 years (standard deviation =
9.6); 76.3% were mothers and 65.7% had up to 8 years of
schooling. Most of the families belonged to the less privi-
leged economic levels; 53.6% pertained to Class C and
35.7% pertained to Classes D and E (low economic level)
(Table 1).
All guardians (n = 190) answered the questionnaires.
Regarding individuals between the ages of 5 and 18 years,
12 (6.3%) did not participate in the study; ten of these
(5.3%) were in the 5–7-year-old age group and two
(1.0%) were in the 8–12-year-old age group. The follow-
ing were the reasons given for refusing to participate: five
(3.7%) did not wish to answer the questionnaires; and
seven (5.1%) did not have the physical capacity necessary
to answer the questionnaires (individuals with malignant
neoplasms in the Central Nervous System and individuals
in the terminal phase). In such cases, only the guardians
participated in the study. One female adolescent with a
syndrome associated with malignant neoplasm was
excluded from the study.
Reliability
Table 2 displays the values obtained during the test-retest
reliability analysis regarding the PedsQL™ 3.0 Cancer
Module subscales. Considering the reports of the chil-
dren/adolescents, all subscales except 'nausea' exhibited
excellent correlation with the Intraclass Correlation Coef-
ficient values (>0.80). Correlation among the guardians
ranged from good to excellent, with values >0.70. Agree-
ment of the items revealed Weighted Kappa Coefficient
values of 0.26–0.85 for the children/adolescents and
0.25–0.87 for the guardians, thereby ranging from regular
to nearly perfect.
Internal consistency was assessed with Cronbach's Alpha
Coefficient regarding the total scale and the different sub-
scales according to the age group of the individuals. The
analysis of the results revealed values greater than 0.70 for
the total scale in all age groups and in both the version
designed for children/adolescents as well as that designed
for guardians. However, when assessing each subscale
separately, the values proved heterogeneous (Table 3).
The analysis of the Corrected Item-Total Correlation Coef-
ficients for the 27 items of the scales revealed values
greater than 0.20 (Table 4).
Validity
The discriminant validity of the PedsQL™ 3.0 Cancer
Module was determined by comparing the scores for
patients in treatment and those off treatment. Analysis
was performed employing the Mann-Whitney test.
According to the scores the children/adolescents
Table 1: Descriptive analyses: demographic characteristics of the 
sample
Demographic 
characteristics
Child/
Adolescent on 
treatment 
(n = 140)
Child/
Adolescent off 
treatment 
(n = 50)
Total sample 
(n = 190)
Child/Adolescent 
characteristics
n%n%n%
Ages (years)
2–4 46 32.9 8 16.0 54 28.4
5 – 7 3 22 2 . 81 02 0 . 04 22 2 . 1
8–12 34 24.3 21 42.0 55 29.0
1 3 – 1 8 2 82 0 . 01 12 2 . 03 92 0 . 5
Gender
Boys 90 64.3 35 70.0 125 65.8
G i r l s 5 03 5 . 71 53 0 . 06 53 4 . 2
Guardians 
characteristics
Ages (years)
18–28 37 26.4 7 14.0 44 23.2
2 9 – 3 4 2 92 0 . 72 24 4 . 05 12 6 . 8
35–39 38 27.2 6 12.0 44 23.2
4 0 – 7 9 3 62 5 . 71 53 0 . 05 12 6 . 8
Relationship to 
patient
M o t h e r 1 0 9 7 7 . 93 67 2 . 0 1 4 5 7 6 . 3
Father 17 12.1 6 12.0 23 12.1
Others (brother/
sister, 
grandmother/
grandfather, aunt/
uncle)
14 10.0 8 16.0 22 11.6
Level of 
schooling
≤ 8  y e a r s 9 26 5 . 73 26 4 . 0 1 2 4 6 5 . 3
>  8  y e a r s 4 83 4 . 31 83 6 . 06 63 4 . 7
Economic level
high (A, B) 15 10.7 5 10.0 20 10.5
i n t e r m e d i a t e  ( C ) 7 55 3 . 62 14 2 . 09 65 0 . 5
low (D, E) 50 35.7 24 48.0 74 39.0Health and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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obtained, the 'nausea', 'procedural anxiety' and 'treatment
anxiety' subscales were capable of differentiating the two
clinically distinct groups. Regarding the scores the guardi-
ans obtained, the two sample groups were differentiated
by the 'pain and hurt', 'nausea' and 'procedural anxiety'
subscales (Table 5).
The subdivision of the sample into three groups of
patients in known distinct clinical conditions ('in treat-
ment', 'off treatment' ≤ 12 months and 'off treatment' > 12
months) demonstrated that the 'nausea', 'procedural anx-
iety' and 'treatment anxiety' subscales were capable of dis-
tinguishing the groups. The Kruskal-Wallis and Mann-
Whitney tests were used for the statistical analysis (Table
6).
Construct validity was measured using Spearman's Corre-
lation Coefficient between the scores obtained on the 8
subscales of the PedsQL™ 3.0 Cancer Module and 1) the
total score; 2) the score referring to physical health and 3)
the score referring to psychosocial health of the PedsQL™
4.0 Generic Core Scale. The values demonstrate that,
despite being statistically significant, correlations were
weak. Furthermore, a weak correlation was observed
between the scores the children/adolescents obtained and
those obtained by the guardians (0.17–0.47) (Table 7).
Discussion
The incidence of childhood cancer is estimated at 100 to
150 cases per million inhabitants per year and has
increased by about 12% in the last 15 years. In assessing
all types of neoplasms in childhood and adolescence, a
greater incidence is observed among boys [18]. In the
present study, the majority of the sample (65.8%) was
made up of males, which is consistent with the literature.
Assessment instruments should be reproducible over
time, that is, they should produce similar results in two or
more administrations to the same individual, provided
that the general clinical state has not been altered. The
analysis of test-retest reliability suggests the adequate sta-
bility of the instrument. The 7-day interval between inter-
views was important in diminishing the probability of
systemic alterations in the clinical condition of the
patient. It is recommended that the interval between
measurements be long enough to reduce the effects of
memory and short enough to diminish the likelihood of
systemic alterations. Although the definition of this inter-
val is arbitrary, a period of 2 to 14 days is considered ade-
quate [16,19-21].
Internal consistency calculated by means of Cronbach's
Alpha Coefficient for the overall scale demonstrated ade-
quate homogeneity (α  ≥ 0.70) for both the version
designed for children/adolescents (α = 0.76) as well as
that designed for guardians (α = 0.84). Procedural anxiety
subscale presented values near to or above 0.70 in all age
groups. Both the 'treatment anxiety' and 'communication'
subscales exhibited values near to or above 0.70, except
for the individuals in the 8–12-year-old age group. The
same was observed for the 'worry' subscale for individuals
in the 13–18-year-old age group. The 'pain and hurt', 'cog-
nitive problems' and 'perceived physical appearance' sub-
Table 2: PedsQL™ 3.0 Cancer Module: Test-retest Reliability 
according to versions designed for children/adolescents and 
guardians
PedsQL™ Subscales Report of child/
adolescent (n = 32)
Report of guardian 
(n = 50)
Pain and hurt 0.86 (0.72–0.93)* 0.71 (0.48–0.83)*
Item 1 0.39# 0.87#
Item 2 0.77# 0.82#
Nausea 0.69 (0.36–0.85)* 0.86 (0.72–0.92)*
Item 1 0.43# 0.49#
Item 2 0.39# 0.25#
Item 3 0.38# 0.30#
Item 4 0.41# 0.61#
Item 5 0.26# 0.51#
Procedural 
anxiety
0.89 (0.77–0.94)* 0.81 (0.67–0.89)*
Item 1 0.46# 0.52#
Item 2 0.55# 0.49#
Item 3 0.66# 0.70#
Treatment 
anxiety
0.87 (0.73–0.94)* 0.85 (0.73–0.91)*
Item 1 0.59# 0.43#
Item 2 0.43# 0.49#
Item 3 0.60# 0.57#
Worry 0.84 (0.68–0.92)* 0.85 (0.73–0.91)*
Item 1 0.43# 0.63#
Item 2 0.51# 0.47#
Item 3 0.53# 0.52#
Cognitive 
problems
0.89 (0.78–0.95)* 0.75 (0.55–0.86)*
Item 1 0.32# 0.34#
Item 2 0.85# 0.34#
Item 3 0.54# 0.45#
Item 4 0.62# 0.38#
Item 5 0.36# 0.72#
Perceived physical 
appearance
0.90 (0.79–0.95)* 0.89 (0.80–0.94)*
Item 1 0.61# 0.67#
Item 2 0.69# 0.52#
Item 3 0.45# 0.63#
Communication 0.82 (0.63–0.91)* 0.93 (0.87–0.96)*
Item 1 0.53# 0.62#
Item 2 0.50# 0.67#
Item 3 0.63# 0.46#
*p ≤ 0.001(2-tailed) Intraclass Correlation Coefficient (ICC) – 
Confidence Interval 95%
#Weighted kappa Coefficient (kw) was calculated for each itemHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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scales presented values below 0.70 regarding the accounts
of the children/adolescents and those of the guardians.
It is interesting to note that the study carried out by Varni
et al. [15] in San Diego and Los Angeles (USA) with 339
families of individuals between the ages of 2 and 18 years
with cancer exhibited Alpha Coefficients of less than 0.70
in various subscales of the versions designed for children/
adolescents. Thus, such subscales were only considered
for descriptive analyses. The low internal consistency may
be related to the small number of items that compose the
subscale [22]. Furthermore, Alpha Coefficient values may
be influenced by the level of schooling in the sample [23].
The analysis of the Corrected Item-Total Correlation
proved the satisfactory homogeneity of the instrument. It
is known that when the correlation coefficient is lower
than 0.20 or 0.30, the item should either be rewritten or
removed from the instrument [14,16].
A number of studies use discriminant validity analysis as
a useful method in the differentiation of groups that are
known to be distinct [1,15,24,25]. The results support the
hypothesis that individuals in treatment would exhibit
low scores on the PedsQL™ Cancer Module when com-
pared to individuals off treatment. Therefore, the occur-
rence of illness implied limitations and difficulties.
It is important to note that the 'nausea' subscale was capa-
ble of discriminating individuals in treatment and indi-
viduals off treatment for a period of ≤ 12 months and
individuals off treatment for >12 months in both the ver-
sion designed for children/adolescents as well as that
designed for guardians. Nausea and vomiting in the first
Table 3: Cronbach's Alpha Coefficient on the versions of the PedsQL™ 3.0 Cancer Module designed for children/adolescents and 
guardians according to subscales and age group
Total sample
PedsQL™ 
Subscales
2–4 (n = 0) 5–7 (n = 32) 8–12 (n = 53) 13–18 (n = 39) n α
Child/
Adolescent
Total scale NA 0.81 0.72 0.80 92 0.76
Pain and hurt NA 0.21 0.46 -0.09 124 0.20
Nausea NA 0.76 0.42 0.63 124 0.62
Procedural anxiety NA 0.73 0.65 0.79 124 0.72
Treatment anxiety NA 0.68 0.37 0.73 124 0.62
Worry NA 0.66 0.65 0.30 124 0.58
Cognitive 
problems
NA 0.36 0.46 0.54 92 0.50
Perceived physical 
appearance
NA 0.28 0.56 0.64 124 0.51
Communication NA 0.68 0.58 0.64 124 0.63
Total sample
PedsQL™ 
Subscales
2–4 (n = 54) 5–7 (n = 42) 8–12 (n = 55) 13–18 (n = 39) n α
Guardians
Total scale 0.75 0.75 0.80 0.88 94 0.84
Pain and hurt 0.33 0.64 0.36 0.65 190 0.50
Nausea 0.49 0.70 0.83 0.81 190 0.75
Procedural anxiety 0.80 0.69 0.75 0.69 190 0.77
Treatment anxiety 0.74 0.67 0.80 0.87 190 0.78
Worry 0.77 0.82 0.75 0.63 190 0.76
Cognitive 
problems
0.49 0.52 0.50 0.65 94 0.55
Perceived physical 
appearance
0.63 0.45 0.66 0.65 190 0.63
Communication 0.79 0.80 0.77 0.63 190 0.76
NA = not applicable
n = number of individualsHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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48 after initiating the chemotherapy treatment cycle are
frequently reported by individuals afflicted with neo-
plasms [26].
The hypothesis was confirmed with regard to the con-
struct validity of the PedsQL™ Cancer Module scale. Indi-
viduals in treatment had lower scores on the PedsQL™
Generic Core Module, as the occurrence of childhood can-
cer implies restrictions to daily living. It is known that
there are frequent occurrences of infection, fatigue, ane-
mia and nausea. Emotional disorders can also be second-
ary reactions to treatment or attributed to a lack of
motivation. Psychological affects, such as a diminished
scholastic performance or capacity for social interaction,
can result in neuropsychological deficiencies attributed to
the toxicity of chemotherapy or the isolation to which the
individual is subjected [9,15].
The analysis of the correlation between the scores the chil-
dren/adolescents obtained and those obtained by the
guardians revealed a weak correlation in all PedsQL™ Can-
cer Module subscales. The same has been found in other
studies [1,9,15]. Thus, the importance of developing
instruments designed for children/adolescents is stressed,
Table 4: PedsQL™ Cancer Module: assessment of Internal Consistency Reliability according to report of the child/adolescent (n = 124) 
and report of the guardian (n = 190)
PedsQL™ Subscales Report of child/
adolescent Item-Total 
Correlation
Report of guardian 
Item-Total 
Correlation
Report of child/
adolescent Corrected 
Item-Total 
Correlation
Report of guardian 
Corrected Item-Total 
Correlation
Correlation between 
child/guardian scores 
(r) (n = 124)
Pain and hurt 0.227*
Item 1 0.73 0.83 0.39 0.60
Item 2 0.75 0.79 0.42 0.56
Nausea 0.470**
Item 1 0.61 0.77 0.37 0.64
Item 2 0.62 0.64 0.46 0.49
Item 3 0.63 0.74 0.50 0.60
Item 4 0.59 0.75 0.40 0.61
Item 5 0.58 0.65 0.44 0.47
Procedural anxiety 0.324**
Item 1 0.78 0.74 0.63 0.57
Item 2 0.83 0.86 0.74 0.75
Item 3 0.67 0.87 0.56 0.74
Treatment anxiety 0.234**
Item 1 0.63 0.74 0.43 0.56
Item 2 0.74 0.88 0.58 0.79
Item 3 0.84 0.86 0.64 0.73
Worry 0.247**
Item 1 0.64 0.80 0.40 0.67
Item 2 0.77 0.87 0.55 0.74
Item 3 0.77 0.78 0.57 0.63
Cognitive 
problems
0.169*
Item 1 0.57 0.53 0.28 0.24
Item 2 0.58 0.67 0.29 0.44
Item 3 0.43 0.49 0.28 0.28
Item 4 0.68 0.66 0.48 0.46
Item 5 0.63 0.66 0.39 0.47
Perceived physical 
appearance
0.214*
Item 1 0.65 0.67 0.24 0.48
Item 2 0.70 0.77 0.36 0.56
Item 3 0.73 0.82 0.40 0.62
Communication 0.200*
Item 1 0.71 0.83 0.52 0.68
Item 2 0.83 0.88 0.67 0.76
Item 3 0.73 0.77 0.47 0.59
*p < 0.05, **p ≤ 0.01 – Spearman's Correlation CoefficientHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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as the concept of quality of life is subjective [27-30]. It is
known that children, even under the age of 5 years, are
capable of describing their perceptions, emotions, feelings
and thoughts [31]. Furthermore, the reports of children/
adolescents and their guardians tend to be similar when
referring to externally perceptible physical symptoms.
However, opinions are quite distinct with regard to sub-
jective issues [27,32].
This study presents limitations that should be recognized.
One difficulty observed in studies on individuals afflicted
with cancer regards the small size of the sample stemming
from the low prevalence of the illness [23,24,33,34]. In
order to broaden this convenience sample, the study
encompassed the two largest childhood neoplasm treat-
ment hospitals in the city of Belo Horizonte, MG, Brazil.
The results will be applicable to a specific population. It
should be pointed out that Brazil is a country of vast cul-
tural diversity, which limits the generalization of results
and implies the need to perform adjustments [35].
It should also be stressed that the scale was developed to
be administered in the form of an interview with children
in the 5–7-year-old age group and self-applied in the other
age groups (8–12 years and 13–18 years) as well as with
the guardians. However, due to the low level of schooling
Table 5: Discriminant validity: analysis of the average and median scores obtained on the PedsQL™ Cancer Module subscales by the 
child/adolescent and guardian according to the clinical condition of the child/adolescent
PedsQL™ 
Subscales 
Child/
Adolescent
On treatment (n = 83) Off treatment (n = 41) Significance
M Median SD M Median SD P value
Pain and hurt 86.7 100.0 18.5 86.3 100.0 18.1 0.727
Nausea 76.4 80.0 19.8 90.1 90.0 9.8 <0.001
Procedural 
anxiety
73.7 83.3 26.5 81.5 100.0 28.3 0.030
Treatment 
anxiety
83.6 100.0 21.2 95.3 100.0 11.8 0.001
W o r r y 5 4 . 85 0 . 03 1 . 26 3 . 46 6 . 72 7 . 3 0 . 1 5 4
Cognitive 
problems
77.9 80.0 21.0 82.5 85.0 16.8 0.322
Perceived 
physical 
appearance
79.7 83.3 22.6 80.5 83.3 25.3 0.600
Communication 78.5 83.3 26.3 79.3 83.3 25.5 0.892
PedsQL™ 
Subscales 
Guardians
On treatment (n = 140) Off treatment (n = 50) Significance
M Median SD M Median SD P value
Pain and hurt 86.6 100.0 22.0 93.8 100.0 15.6 0.048
Nausea 79.9 90.0 22.2 91.7 100.0 14.3 <0.001
Procedural 
anxiety
46.3 50.0 34.7 58.2 66.7 39.5 0.035
Treatment 
anxiety
69.1 83.3 33.8 72.2 83.3 34.6 0.437
Worry 78.8 100.0 30.3 77.8 91.7 27.5 0.537
Cognitive 
problems
82.0 87.5 20.1 84.6 90.0 20.3 0.403
Perceived 
physical 
appearance
77.4 83.3 28.3 83.3 100.0 22.8 0.300
Communication 69.4 83.3 36.8 76.2 83.3 28.3 0.581
PedsQL™: Pediatric Quality of Life; M: mean; SD: standart deviation
Higher scores on the subscales of the PedsQL™ Cancer Module indicate less difficulties/limitationsHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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among the individuals who participated in the present
study, the option was made to administer the question-
naire in the form of an interview in all cases. A number of
studies have demonstrated that the mode of administra-
tion does not affect the performance of the instruments
[21,30]. Nevertheless, a comparison between the inter-
view mode of administration and self-administered mode
of administration needs further investigation. Finally,
there was no report by the patients or guardians of any
lack of comprehension regarding the questions.
The lack of validation studies on assessment scales of the
quality of life among children and adolescents with cancer
in Brazil hinders comparisons with the results obtained
here. Furthermore, the PedsQL™ 3.0 Cancer Module' is
currently undergoing validation processes in a number of
countries, which have only been concluded in Germany
thus far [33].
Conclusion
The Brazilian version of the PedsQL™ Cancer Module 3.0
presented adequate properties regarding the validity of the
Table 6: Kruskal-Wallis Test values: comparison between PedsQL™ Cancer Module scores for individuals on treatment and off 
treatment (≤ 12 months or > 12 months)
Child/Adolescent report Guardians report
PedsQL Subscales n Mean 
Rank
Difference Kruskal 
Wallis 
test
P value n Mean 
Rank
Difference Kruskal 
Wallis test
P value
Pain and hurt
On Tx(a) 83 63.22 0.128 0.938 141 91.72 3.541 0.170
Off Tx ≤ 12(b) 20 60.65 22 104.98
Off Tx > 12(c) 21 61.43 27 107.52
Nausea a,c***; a,b** 15.331 0.000 a,c*** 17.415 0.000
On Tx(a) 83 53.88 141 86.67
Off Tx ≤ 12(b) 20 75.45 22 106.91
Off Tx > 12(c) 21 84.24 27 132.31
Procedural 
anxiety
4.994 0.082 a,b* 5.871 0.053
On Tx(a) 83 57.75 141 90.46
Off Tx ≤ 12(b) 20 74.93 22 119.45
Off Tx > 12(c) 21 69.45 27 102.30
Treatment 
anxiety
a,c** 11.369 0.003 4.378 0.112
On Tx(a) 83 55.99 141 94.12
Off Tx ≤ 12(b) 20 71.00 22 116.16
Off Tx > 12(c) 21 80.14 27 85.85
Worry 2.963 0.227 3.289 0.193
On Tx(a) 83 59.29 141 97.12
Off Tx ≤ 12(b) 20 63.48 22 77.82
Off Tx > 12(c) 21 74.26 27 101.43
Cognitive 
problems
1.196 0.550 1.459 0.482
On Tx(a) 83 60.28 141 93.99
Off Tx ≤ 12(b) 20 64.35 22 108.32
Off Tx > 12(c) 21 69.52 27 92.94
Perceived 
physical 
appearance
0.442 0.802 0.949 0.622
On Tx(a) 83 61.36 141 93.55
Off Tx ≤ 12(b) 20 67.08 22 104.43
Off Tx > 12(c) 21 62.67 27 98.43
Communication 0.178 0.915 0.462 0.794
On Tx(a) 83 62.2 141 94.06
Off Tx ≤ 12(b) 20 65.3 22 101.36
Off Tx > 12(c) 21 61.0 27 98.24
On Tx: in-treatment sample; Off Tx ≤ 12: off-treatment ≤ 12 months sample; Off Tx > 12: off-treatment > 12 months long-term survivor sample
*p < 0.05, **p ≤ 0.01, ***p ≤ 0.001 based on Mann-Whitney TestHealth and Quality of Life Outcomes 2008, 6:7 http://www.hqlo.com/content/6/1/7
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construct. The adequate reproducibility and good validity
of the scale suggest its usefulness as a parameter in studies
assessing the impact of neoplasms on the quality of life of
children and adolescents. Further investigation of the Bra-
zilian Portuguese language instrument should focus on
testing sensitivity and responsiveness in longitudinal
studies and providing a data comparison to healthy Bra-
zilian children and adolescents.
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